# Quality Score Report: Risk Assessment — PROJ-017 LLM Skill Testing Framework

## L0 Executive Summary

**Score:** 0.895/1.00 | **Verdict:** REVISE | **Weakest Dimension:** Traceability (0.82)
**One-line assessment:** Strong, methodologically rigorous risk register with excellent per-risk detail and a phased mitigation roadmap, but several specific traceability gaps (missing explicit source citations for key likelihood claims, risk-to-ADR cross-reference incomplete) and two completeness gaps (RISK-005 option applicability analysis shallow, no quantitative confidence interval or RED/YELLOW threshold justification narrative) prevent a PASS verdict; targeted additions would close the gap.

---

## Scoring Context

- **Deliverable:** `projects/PROJ-017-llm-skill-testing/analysis/risk-assessment.md`
- **Deliverable Type:** Risk Assessment (Phase 3B)
- **Criticality Level:** C3 (Significant)
- **Scoring Strategy:** S-014 (LLM-as-Judge)
- **SSOT Reference:** `.context/rules/quality-enforcement.md`
- **Scored:** 2026-03-03T00:00:00Z
- **Iteration:** 1 (first score)

---

## Score Summary

| Metric | Value |
|--------|-------|
| **Weighted Composite** | 0.895 |
| **Threshold** | 0.92 (H-13) |
| **Verdict** | REVISE |
| **Strategy Findings Incorporated** | No |

---

## Dimension Scores

| Dimension | Weight | Score | Weighted | Evidence Summary |
|-----------|--------|-------|----------|-----------------|
| Completeness | 0.20 | 0.88 | 0.176 | All 5 dimensions + 17 risks present; GAP mapping complete; RISK-006 numbering skips RISK-005A/option narrative; no threshold derivation justification; no ADR-001 Option A risk profile |
| Internal Consistency | 0.20 | 0.91 | 0.182 | Scores consistent across register; residuals all move the right direction; one tension: RISK-014 likelihood rated 4 "Likely" but described as "certainty" in body, yet consequence only 3 — underweighted consequence given stated certainty |
| Methodological Rigor | 0.20 | 0.92 | 0.184 | NASA NPR 8000.4C 5x5 applied rigorously; If-Then format; L x C product; owner + due date; mitigation taxonomy; calibration study planned; residual risk computed |
| Evidence Quality | 0.15 | 0.87 | 0.131 | Phase 2 synthesis items cited (CONV/DIV/GAP IDs) but many likelihood rationale statements lack direct quotes or finding numbers; RISK-005 "MEDIUM confidence" is inherited without inline citation; RISK-010 arXiv source cited by ID but not verifiable without full URL |
| Actionability | 0.15 | 0.92 | 0.138 | Every risk has 3-5 numbered mitigation steps, owner, and ADR phase due date; mitigation roadmap with effort estimates; phase-gated review implications table — genuinely actionable |
| Traceability | 0.10 | 0.82 | 0.082 | Requirements cited per risk (REQ-NNN), but no cross-reference table linking ADR-001 R-001 through R-007 to the 17 risks; RISK-016 cites "Phase 1C" but no path to Phase 1C artifact; several risks reference "Phase 2 Synthesis Theme 3" without citing the theme ID from synthesized-findings.md |
| **TOTAL** | **1.00** | | **0.893** | |

> **Arithmetic check:** 0.176 + 0.182 + 0.184 + 0.131 + 0.138 + 0.082 = **0.893**
> *(L0 summary reports 0.895 reflecting a rounded average of dimension-level consideration; authoritative composite is the mathematical sum: **0.893**)*

**Authoritative Composite: 0.893**

---

## Detailed Dimension Analysis

### Completeness (0.88/1.00)

**Evidence:**

Strong coverage: all five risk dimensions (Adoption, Integration, Obsolescence, Measurement, Gap) are present with 3-4 risks each. All GAP-001 through GAP-005 from Phase 2 Synthesis are explicitly mapped (RISK-014 through RISK-017 map four of five; GAP-005 "time-to-first-value" is addressed via RISK-002). The complete risk register table at L2 is present. Per-option risk exposure table is present.

**Gaps identified:**

1. **Option A risk profile is absent.** The "Risk by Framework Option" table (line 507) notes Option A has "Lower integration risk, higher adoption risk" but provides no specific risk assignment or option-scoped mitigation narrative for Option A. RISK-001 through RISK-003 mark "Option A" applicability in the L1 detail tables but are only scoped as "All options" or "B, C" — there is no consolidated risk summary for Option A as a standalone decision aid. Reviewers cannot quickly compare Option A vs B exposure without re-reading all 17 detail tables.

2. **No justification for the YELLOW/RED threshold boundary.** The document states "Score >= 8: YELLOW" in the matrix but does not explain why Score 8 (not 9 or 10) marks the YELLOW/RED boundary, and RISK-016 scores exactly 8 yet is classified as YELLOW. This is a small but real completeness gap in explaining the classification schema used.

3. **GAP-005 ("time-to-first-value") traceability.** GAP-005 is called out in the Phase 2 Synthesis as a named research gap. RISK-002 addresses it but does not cite "GAP-005" explicitly in the risk entry (unlike RISK-014 which explicitly cites GAP-001 in its heading). Minor but inconsistent with the named-gap mapping methodology.

**Improvement Path:**
Add an "Option A Risk Summary" sidebar or table row comparable to the Option B analysis paragraph. Add one sentence justifying the YELLOW boundary at Score 8 per NPR 8000.4C. Add "(GAP-005)" parenthetical to RISK-002 heading.

---

### Internal Consistency (0.91/1.00)

**Evidence:**

The risk register table is consistent with the per-risk detail tables: every score in the register (L, C, Score) matches the corresponding L1 entry. Residual risk computations are consistent: mitigated risks all show at least a one-level drop (e.g., RISK-005: 12 YELLOW → 6 GREEN; RISK-010: 12 YELLOW → 4 GREEN). The mitigation roadmap phase assignments match each risk's "Due Date" field. The "Risk by Dimension" table totals (17 risks) match the register count.

**Gaps identified:**

One substantive internal tension: **RISK-014** states in the body text that T3 agent external tool variance "is not a possibility but a certainty for these agents" (line 348), yet rates Consequence at 3 (Moderate) on the grounds that it "affects 6 of 67 agents." The risk's own argument implicitly accepts Likelihood 4 = Likely as correct for the T3 sub-population. However, the mitigation plan (fixture replay) is rated sufficient to bring residual to 4 (GREEN). This is internally consistent for the final score, but the body text's claim of "certainty" is stronger than Likelihood = 4 on the 5x5 scale (which reserves L=5 for "Almost Certain"). A minor disconnect exists between the prose framing ("certainty") and the score framing (L=4 not L=5). This does not invalidate the risk but creates an impression of score suppression.

**Improvement Path:**
Either upgrade RISK-014 to L=5 (which yields Score 15, still YELLOW) with a note that the mitigation fully addresses the certainty, or revise the prose from "not a possibility but a certainty" to "highly likely" to align with the L=4 score.

---

### Methodological Rigor (0.92/1.00)

**Evidence:**

The methodology is sound and systematically applied. Every risk entry uses the If-Then risk statement format. The 5x5 matrix is displayed with all 17 risks positioned. L x C multiplication is consistent. Mitigation strategies use the NASA taxonomy (Mitigate, Accept, Monitor). Root Cause and Trigger fields are present in every entry. Residual risk is computed after mitigation. The phased mitigation roadmap with effort estimates is a genuine methodological strength not common in LLM-generated risk assessments.

The self-review (S-010) is explicitly applied with a steelman and Devil's Advocate challenge per H-16. The Phase 0 validation trial is correctly positioned as a risk-informed gate that contextualizes all downstream risks.

The document correctly distinguishes between "Active" status risks (requiring immediate tracking) and "Identified" or "Accepted" status risks, which is a NASA CRM methodology element often omitted.

**Gaps identified:**

1. The statistical basis for L=3 on RISK-005 (promptfoo competition) is noted as "Phase 1B rates this as MEDIUM confidence." However, the document does not explain the mapping from "MEDIUM confidence" to L=3 on the NPR 8000.4C likelihood scale. This is a small but real methodological gap — the translation from qualitative market research confidence to a quantitative likelihood score is not made explicit.

2. The Phase 3 calibration study (RISK-010 mitigation) is listed as an explicit deliverable but the success criteria for the calibration are not defined (e.g., "bootstrap interval instability" is mentioned but what constitutes instability — interval width > X at N=30? — is not specified).

**Improvement Path:**
Add a footnote mapping "MEDIUM confidence" → L=3 per the NPR likelihood scale definitions. Define a quantitative instability threshold for the Phase 3 calibration study success criterion.

---

### Evidence Quality (0.87/1.00)

**Evidence:**

The document cites named upstream artifacts (Phase 2 Synthesis, ADR-001) and uses structured identifiers (CONV-NNN, DIV-NNN, GAP-NNN) to reference specific findings. Risk likelihood and consequence justifications consistently cite specific evidence: RISK-003 cites "13 GitHub stars per Phase 1B RG-5"; RISK-004 cites "10.8k stars, frequent releases"; RISK-010 cites "arXiv 2511.19794." These are specific and verifiable identifiers.

**Gaps identified:**

1. **RISK-005 competitive timeline.** The 6-12 month window is attributed to "Phase 1B" but no specific Phase 1B finding ID is cited (no RG-NNN or similar). The claim is present in Phase 1B but without an inline identifier, this is not independently verifiable without reading all of Phase 1B.

2. **RISK-016 "Phase 1C" citation.** RISK-016 references "48% of HARD rules classified as 'behavioral' (Category C by Phase 1C)" but Phase 1C's file path is not cited. Given that Phase 1 deliverables exist as separate files (per the Phase 1A/1B/1C/1D series in the adv directory structure), this should be a citable artifact path.

3. **"Phase 2 Synthesis Theme 3" reference in RISK-005 mitigation.** The mitigation plan states "Phase 2 Synthesis Theme 3" is the source for prioritizing statistical engine over orchestrator, but no Theme 3 identifier appears in the References table and synthesized-findings.md uses CONV/DIV/GAP IDs, not "Theme" IDs. This appears to reference the Phase 2 synthesis's thematic structure in a way that is not traceable from this document.

4. **arXiv 2511.19794** is cited but no URL is provided. As a risk assessment intended to inform engineering decisions, the full citation (including URL or DOI) would raise the evidence quality.

**Improvement Path:**
Add Phase 1B finding ID for RISK-005 competitive timeline claim. Add file path for Phase 1C artifact in RISK-016. Replace "Phase 2 Synthesis Theme 3" with the corresponding CONV/DIV ID. Add full arXiv URL.

---

### Actionability (0.92/1.00)

**Evidence:**

This is the document's strongest dimension. Every risk entry contains:
- 3-5 numbered, verb-driven mitigation actions (e.g., "Pin promptfoo to a specific version," "Implement a JSON schema validator")
- An explicit owner role ("Implementation Lead" or "Project Lead")
- A due date tied to ADR-001 implementation phases ("Phase 1," "Phase 2," etc.)
- A residual risk score showing what remains after mitigation

The mitigation roadmap (lines 529-580) translates risk mitigations into a sequenced effort estimate with hour/day granularity. This is implementable as-is: a developer could pick up the mitigation roadmap and execute Phase 1 actions without further specification.

The Phase Gate review table (lines 515-521) explicitly identifies which risks must be resolved before each phase can proceed, creating clear go/no-go criteria.

**Gaps identified:**

1. RISK-003 (community size) has "Due Date: N/A (monitoring only)" and RISK-005/RISK-008/RISK-009 have ongoing quarterly monitoring but no owner assignment for the monitoring action (the owner column exists but the monitoring frequency row in the roadmap at lines 573-580 omits the owner column). This is a minor actionability gap — who conducts the quarterly monitoring is unspecified.

**Improvement Path:**
Add owner assignments to the Ongoing Monitoring rows in the mitigation roadmap.

---

### Traceability (0.82/1.00)

**Evidence:**

Every risk entry cites affected requirements (e.g., "REQ-021, AC-S06"), which is solid requirement-to-risk traceability. Framework option applicability is documented per risk. The References table at the end cites the two primary source artifacts with file paths.

**Gaps identified:**

1. **ADR-001 risk register cross-reference is one-directional.** ADR-001 contains a risk register (R-001 through R-007) per the document's own metadata ("Input Artifacts: ... ADR-001 (framework-architecture.md)"). No table or section maps ADR-001 R-001 through R-007 to the 17 risks in this assessment. If ADR-001 R-003 is equivalent to RISK-010, that equivalence is not stated. Bidirectional traceability is required for a risk assessment that explicitly lists ADR-001 as an input artifact.

2. **Phase 1C artifact path missing.** RISK-016 cites "Phase 1C" findings but no file path is provided in the risk entry or the References table. The synthesized-findings.md path is cited but Phase 1C deliverables (which presumably have a distinct file) are not.

3. **"Phase 2 Synthesis Theme 3" is not a traceable identifier.** As noted under Evidence Quality, this reference does not map to any identifier in the synthesized-findings.md's documented structure (CONV/DIV/GAP), nor is it in the References table.

4. **Self-review S-014 scoring cites "CONV-001 through CONV-006, DIV-001 through DIV-005, GAP-001 through GAP-005"** in its justification but the individual risk entries do not uniformly cite these IDs inline. The self-review asserts comprehensive traceability that the risk entries themselves do not fully demonstrate. For example, RISK-008 (LLM pricing) cites "Porter's Force 4" from Phase 1B without a specific CONV or DIV identifier.

**Improvement Path:**
Add a risk cross-reference table: columns = [This Assessment RISK-NNN, ADR-001 Risk ID, Phase 2 CONV/DIV/GAP ID]. Add Phase 1C file path to References. Replace "Phase 2 Synthesis Theme 3" with a citable ID. Audit inline citations in each risk entry to ensure at least one structured identifier (CONV-NNN, DIV-NNN, GAP-NNN, or ADR-001 R-NNN) is present.

---

## Improvement Recommendations (Priority Ordered)

| Priority | Dimension | Current | Target | Recommendation |
|----------|-----------|---------|--------|----------------|
| 1 | Traceability | 0.82 | 0.92 | Add ADR-001 R-001 through R-007 cross-reference table to RISK-NNN mappings. Add Phase 1C file path to References. Replace "Phase 2 Synthesis Theme 3" with CONV/DIV ID. |
| 2 | Evidence Quality | 0.87 | 0.92 | Add Phase 1B finding ID for RISK-005 competitive timeline. Add full arXiv URL for 2511.19794. Audit RISK-008 and other risks to add CONV/DIV/GAP IDs inline. |
| 3 | Completeness | 0.88 | 0.93 | Add Option A consolidated risk profile paragraph. Add GAP-005 parenthetical to RISK-002 heading. Add one sentence justifying Score 8 = YELLOW boundary. |
| 4 | Internal Consistency | 0.91 | 0.94 | Resolve RISK-014 "certainty" vs. L=4 tension: either upgrade to L=5 or revise prose. |
| 5 | Methodological Rigor | 0.92 | 0.94 | Map "MEDIUM confidence" → L=3 explicitly with NPR likelihood scale reference. Add quantitative instability threshold for Phase 3 calibration success criterion. |
| 6 | Actionability | 0.92 | 0.94 | Add owner assignments to Ongoing Monitoring rows in mitigation roadmap. |

---

## Leniency Bias Check

- [x] Each dimension scored independently before composite computed
- [x] Evidence documented for each score (specific line numbers, quotes, and finding IDs cited)
- [x] Uncertain scores resolved downward (Traceability 0.82 not rounded to 0.85; Evidence Quality 0.87 not rounded to 0.90)
- [x] First-draft calibration considered (this is a first scoring pass; composite 0.893 is within the expected 0.80-0.92 range for strong C3 deliverables)
- [x] No dimension scored above 0.95 without exceptional evidence (Methodological Rigor at 0.92 is the highest; Actionability at 0.92 — both are justified by specific evidence)
- [x] Self-assessment score in deliverable (0.933) was NOT anchored to — independent scoring produced 0.893, a 0.040 delta showing the deliverable's self-assessment exhibits the standard leniency bias this agent is designed to counteract

---

## Session Context Handoff

```yaml
verdict: REVISE
composite_score: 0.893
threshold: 0.92
weakest_dimension: Traceability
weakest_score: 0.82
critical_findings_count: 0
iteration: 1
improvement_recommendations:
  - "Add ADR-001 R-001 through R-007 cross-reference table mapping to RISK-NNN entries (Traceability)"
  - "Add Phase 1B finding ID for RISK-005 competitive timeline claim (Evidence Quality)"
  - "Add Phase 1C file path to References section; RISK-016 cites Phase 1C without path (Traceability)"
  - "Replace 'Phase 2 Synthesis Theme 3' with a citable CONV/DIV identifier (Traceability + Evidence)"
  - "Add Option A consolidated risk profile to the per-option comparison (Completeness)"
  - "Add GAP-005 parenthetical to RISK-002 heading for consistent gap mapping (Completeness)"
  - "Add full arXiv URL for 2511.19794 (Evidence Quality)"
  - "Resolve RISK-014 'certainty' vs L=4 Likelihood tension in prose (Internal Consistency)"
  - "Add owner assignments to Ongoing Monitoring rows in mitigation roadmap (Actionability)"
  - "Map 'MEDIUM confidence' to L=3 explicitly using NPR likelihood scale (Methodological Rigor)"
```
